Read the full story: Religion Dispatches
Once exclusive to Western counterculture, psychedelics have increasingly drawn the attention of medical researchers, corporations, and politicians. In April, Donald Trump signed an executive order—apparently inspired by podcaster Joe Rogan—to promote research on psychedelic substances like ibogaine or psilocybin. With the latest research already suggesting that psychedelics might help with everything from postpartum depression, PTSD, and fentanyl cravings, to the effects of aging, the president’s EO should be a boon to venture capitalists seeking to cash in.